John Brown - St Jude Independent Presiding Director

Director

Mr. John W. Brown is Independent Presiding Director of St. Jude Medical Inc. since 2006. Chairman of the Board of Stryker Corporation an orthopedic device company from 1997 through December 2009. Chief Executive Officer of Stryker Corporation from 1977 through 2004. Chairman Emeritus of Stryker Corporationrationration. since 2006.
Age 80
Tenure 18 years
Phone651 756-3301
Webwww.sjm.com
Brown served as the Chief Executive Officer of Stryker Corporationration from 1977 to 2004 and as Chairman from 1980 until his retirement in 2009. During his tenure as head of Stryker, Mr. Brown turned a small medical instruments company with annual sales of $17 million and 400 employees into a global orthopedics medical device manufacturer that at the time of his retirement had annual sales of approximately $6.7 billion and over 18, 000 employees. Between 1979 and 2007, Stryker increased annual per share earnings by at least 20 percent every year but two.

St Jude Management Efficiency

St Jude's management efficiency ratios could be used to measure how well St Jude manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 6.39 B in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. St Jude Medical has a current ratio of 1.89, which is typical for the industry and considered as normal. Debt can assist St Jude until it has trouble settling it off, either with new capital or with free cash flow. So, St Jude's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like St Jude Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for STJ to invest in growth at high rates of return. When we think about St Jude's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Michael CawleyRyanair Holdings PLC
63
Marion BlakeyAlaska Air Group
72
James OsborneRyanair Holdings PLC
67
Christine SpadaforBoyd Gaming
65
Phyllis CampbellAlaska Air Group
66
Carlo MontagnaCorporacion America Airports
56
Richard FlahertyBoyd Gaming
73
Raymond ConnerAlaska Air Group
65
Susan LiAlaska Air Group
35
Kenneth ThompsonAlaska Air Group
63
Richard MillikenRyanair Holdings PLC
66
Peter ThomasBoyd Gaming
71
James BeerAlaska Air Group
60
Stan McCarthyRyanair Holdings PLC
59
Daniel ElwellAlaska Air Group
61
Roisin BrennanRyanair Holdings PLC
53
Edward WilsonRyanair Holdings PLC
53
Paul WhetsellBoyd Gaming
70
Matthew HartAir Lease
69
ron SugarAir Lease
66
Billy McCoyBoyd Gaming
73
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical (STJ) is traded on New York Stock Exchange in USA and employs 18,000 people.

Management Performance

St Jude Medical Leadership Team

Elected by the shareholders, the St Jude's board of directors comprises two types of representatives: St Jude inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STJ. The board's role is to monitor St Jude's management team and ensure that shareholders' interests are well served. St Jude's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, St Jude's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Lamb, Managing Director, Executive Director
Baroness Wheatcroft, Non-Executive Independent Director
Ian Gascoigne, Managing Director, Executive Director
John Heinmiller, Executive VP
Tony Dunk, Director - Investor Relations
Denis Gestin, President of International Division
Craig Gentle, CFO
Stephan Widensohler, Independent Director
Donald Zurbay, CFO and VP of Fin.
Lisa Andrade, Chief Marketing Officer
Wendy Yarno, Independent Director
Iain Cornish, Senior Independent Non-Executive Director
Richard Devenuti, Independent Director
Sarah Bates, Non-Executive Chairman of the Board
Jeffrey Dallager, Vice President Corporate Controller
Joel Becker, President - Americas Division
Stuart Essig, Independent Director
Andrew Croft, CFO, Executive Director
Barbara Hill, Independent Director
David Bellamy, Chief Executive, Executive Director
Roger Yates, Independent Non-Executive Director
John Brown, Independent Presiding Director
Daniel Starks, Executive Chairman
Eric Fain, Group President - St. Jude Medical
Elizabeth Kelly, Company Secretary
Rachel Ellingson, Vice President - Corporate Relations
Mark Carlson, Vice President - Global Clinical Affairs, Chief Medical Officer
Paul Bae, Chief Marketing Officer, Vice President - Global Human Resources
Michael Rousseau, CEO and President COO and Director
Mark Murphy, CIO and VP of Information Technology
Scott Thome, Vice President - Global Operations and Supply Chain
Michael Rocca, Independent Director
Simon Jeffreys, Independent Non-Executive Director
Jeff Fecho, Vice President - Global Quality
Jason Zellers, Vice President General Counsel, Corporate Secretary
J Weigelt, Director - Investor Relations
David Dvorak, Director
Robert Gardner, Director of Investment Management
Stefan Widensohler, Independent Director

STJ Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is St Jude a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in STJ Stock

If you are still planning to invest in St Jude Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the St Jude's history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings